Your Cart is Empty
Start shopping
STYLAGE® L BI-FLEX® with Lidocaine
$189.00
/unitProduct details
- Brand:
- STYLAGE®
- Manufacturer:
- Vivacy
- Active Substance(s):
- CROSS-LINKED HYALURONIC ACID (HA), MANNITOL, LIDOCAINE
- Strength:
- 24mg/g HA, 9mg/ml Mannitol, 3mg/ml Lidocaine
- Pack size:
- 2 x 1ml Pre-Filled Syringes, 4 x 30G ½ Needles
Product description
STYLAGE® L BI-FLEX® with Lidocaine is a cross-linked hyaluronic acid injectable dermal filler using IPN-Like Technology™, formulated with 24mg/g hyaluronic acid, 9mg/mL mannitol, and 3mg/mL lidocaine. It is used in aesthetic medicine to correct deep wrinkles, address volume loss, treat nasolabial folds and marionette lines, and enhance facial contouring. Each pack contains 2 × 1mL prefilled syringes for subcutaneous/subdermal injection. Are you looking to buy STYLAGE® L BI-FLEX® with Lidocaine online? Contact Doctor Medica’s staff for guidance on how to find qualified suppliers and supporting documentation.
Tier
| Packs | Discount (%) | For Each |
|---|---|---|
| 1 - 5 | — | $189.00 |
| 6 - 10 | 1.06 % | $187.00 |
| 11 - 20 | 2.12 % | $185.00 |
| 21+ | 2.65 % | $184.00 |
Shop with Confidence: Product Authenticity is Guaranteed
All products available at Doctor Medica shop are obtained from respective manufacturers and contain original LOT numbers Contact us if you have any questions about product LOT numbers.
FAQ
STYLAGE® L BI-FLEX® with Lidocaine is a cross-linked hyaluronic acid dermal filler manufactured by Laboratories VIVACY in France. It uses IPN-Like Technology™ and BI-FLEX® rheology and contains 24mg/g HA with lidocaine for injection comfort. The STYLAGE® range is CE-marked for use in the EU, subject to local regulatory requirements.
STYLAGE® L BI-FLEX® with Lidocaine is used for deep wrinkle correction, including nasolabial folds and marionette lines, as well as facial volume restoration and contouring. Injection depth may involve the mid-to-deep dermis, subdermal plane, or subcutaneous plane, depending on the treatment plan. Use should be limited to licensed professionals trained in aesthetic injection procedures.
STYLAGE® filler longevity is commonly described as approximately 12–18 months, but actual duration varies. Factors such as treatment area, injection technique, skin type, tissue movement, lifestyle, and condition of the patient’s skin can all affect persistence. Mannitol may help limit oxidative degradation of HA, but individual outcomes are not guaranteed.
STYLAGE® products are CE-marked and clinically used in professional aesthetic medicine. The STYLAGE® L BI-FLEX® with Lidocaine formulation incorporates IPN-Like Technology™ for cohesivity, mannitol as an antioxidant to support HA longevity, and lidocaine for injection comfort. Suitability for a specific patient or indication should be determined by the practitioner’s assessment based on the treatment area, anatomy, and clinical objectives.
The STYLAGE® range is CE-marked for use in the EU, but the current US FDA status should be verified before use. FDA approval for dermal fillers is product- and indication-specific. Practitioners should confirm jurisdiction-specific regulatory status before procurement, discussion, or administration.
Common side effects include bruising, redness, swelling, tenderness, pain, itching, firmness, or mild nodularity at the injection site. These reactions commonly resolve within a few days. Worsening pain, change in skin color, blanching, livedo, or visual symptoms require urgent clinical evaluation.
BI-FLEX® refers to an optimized rheological profile associated with this updated product presentation, intended to support controlled extrusion, smooth injection, and cohesive gel placement. This is distinct from IPN-Like Technology™, which applies to the broader STYLAGE® range. Product choice should be based on indication, tissue plane, anatomy, and practitioner judgment rather than on a general comparison between presentations.
Citations
- Kablik J, Monheit GD, Yu L, Chang G, Gershkovich J. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009;35(suppl 1):302–312. doi:10.1111/j.1524-4725.2008.01046.x
- Tran C, Carraux P, Micheels P, Kaya G, Salomon D. In vivo bio-integration of three hyaluronic acid fillers in human skin: a histological study. 2014;228(1):47–54. doi:10.1159/000354514
- Beasley KL, Weiss MA, Weiss RA. Hyaluronic acid fillers: a comprehensive review. Facial Plast Surg. 2009;25(2):86–94. doi:10.1055/s-0029-1220645
For licensed medical professionals only. This content is for informational purposes only and does not constitute medical advice.
